EPO and anemia: This aligns with existing literature emphasizing the increased susceptibility to anemia in CKD patients due to factors such as erythropoietin deficiency, iron metabolism disturbances, and chronic inflammation induced by renal dysfunction leading to alterations in ferritin, hepcidin, and transferrin [13].